Differences in Timely Cancer Diagnosis in African American and Caucasian Patients With Newly Diagnosed Colorectal Cancer
Appraisal Delay and Disparities in Timely Cancer Diagnosis
3 other identifiers
observational
84
1 country
4
Brief Summary
RATIONALE: Gathering information about timely diagnosis in African American and Caucasian patients with newly diagnosed colorectal cancer may help doctors learn more about factors that influence a diagnosis and plan the best treatment. PURPOSE: This phase I trial is studying differences in timely cancer diagnosis in African American patients and in Caucasian patients with newly diagnosed colorectal cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2008
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2008
CompletedFirst Submitted
Initial submission to the registry
March 4, 2009
CompletedFirst Posted
Study publicly available on registry
March 5, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedJuly 16, 2014
July 1, 2014
1.9 years
March 4, 2009
July 14, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Factors that influence appraisal and diagnostic delay
45-60 minute interview
Study Arms (4)
African American Female
African American Male
Caucasian Female
Caucasian Male
Interventions
Patient charts are reviewed to obtain medical data.
Patients undergo a 45-60 minute interview to obtain information on variations in symptom perception, assessment, and patient-physician communication process. Patients are assessed by sociodemographic characteristics (i.e, education, gender, age, insurance status, employment status, income, race/ethnicity, and religiosity), information of close confidants (i.e., relationship, family history of cancer, and caregiver/decision-making status), and physician characteristics. Patients are also assessed by the Trust in the Health Care System, DMPQ, RCS, Brief COPE scale, Lukwago Religiosity scale, and RAND Social Support Survey questionnaires.
Patients are assessed by sociodemographic characteristics (i.e, education, gender, age, insurance status, employment status, income, race/ethnicity, and religiosity).
Patients are also assessed by the Trust in the Health Care System, DMPQ, RCS, Brief COPE scale, Lukwago Religiosity scale, and RAND Social Support Survey questionnaires.
Eligibility Criteria
African American patients and Caucasian patients with newly diagnosed colorectal cancer.
You may qualify if:
- years of age or older
- Cognitively able to participate in an interview
- Diagnosed with Colorectal cancer
- Patient at University Hospitals, Case Western Reserve University, or Cleveland Clinic Foundation
- diagnosed within 6 months of the scheduled interview
- have no prior history of colon cancer or cancer of any other major organ system
- any stage of cancer
- Patient will have described their symptoms to their PCPs
- Patient will have acted as their own decision maker
- Must be African American or Caucasian
You may not qualify if:
- No disease discovered by previous routine screening or by other unintentional detection procedure (i.e., without symptom appraisal process or communicating specific symptoms to physicians)
- Not living in nursing or assisted living facilities
- Cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Case Comprehensive Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (4)
Lake/University Ireland Cancer Center
Cleveland, Ohio, 44060, United States
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Cleveland, Ohio, 44106-5065, United States
Southwest General Health Center
Cleveland, Ohio, 44130, United States
UH-Green Road
South Euclid, Ohio, 44121, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sonja Harris-Haywood, MD
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2009
First Posted
March 5, 2009
Study Start
November 1, 2008
Primary Completion
October 1, 2010
Study Completion
January 1, 2014
Last Updated
July 16, 2014
Record last verified: 2014-07